EGFR and neoplasm: Our data indicating that the combination of gefitinib with cisplatin is antagonistic (in TE8 and OE21 cells) are at odds with reports that treatment of TE8 xenograft tumours with cisplatin in combination with EGFR inhibition by cetuximab significantly reduces their size [44].